Orexigen Therapeutics Inc (NASDAQ:OREX)

5.64
Delayed Data
As of Feb 27
 -0.23 / -3.92%
Today’s Change
3.11
Today|||52-Week Range
7.82
-6.93%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 8.00. The median estimate represents a +77.30% increase from the last price of 5.64.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$7.2M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -122.40%
 
 
 
 
 
 

Sales

Growthquarterly -68.52%
 
 
 
 
 
 
Growthannually -45.16%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account